Preferred Label : wet macular degeneration;

MeSH definition : A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.;

MeSH synonym : degenerations, wet macular; macular degenerations, wet; degeneration, wet macular; macular degeneration, wet; wet macular degenerations;

Details


Main resources

You can consult :

A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.

https://www.cochrane.org/fr/CD015522/EYES_lintelligence-artificielle-ia-est-elle-meilleure-que-lhomme-pour-diagnostiquer-la-degenerescence
2024
United Kingdom
review of literature
french abstract
macular degeneration
artificial intelligence
macule, nos
diagnosis
intelligence, nos
Age-Related Macular Degeneration
elderly man
macular degeneration
humans
wet macular degeneration

---
https://www.cosprc.ca/fr/sustained-funding-to-ensure-access-to-anti-vascular-endothelial-growth-factor-drugs-2019/
2019
false
false
false
false
Canada
drug costs
wet macular degeneration
wet macular degeneration
Ranibizumab
Ranibizumab
aflibercept
aflibercept
Bevacizumab
Bevacizumab
macular edema
diabetic retinopathy
wet macular degeneration
insurance, health, reimbursement
canada
retinal diseases
guidelines
VEGF inhibitors
vascular endothelial growth factors
recombinant fusion proteins
receptors, vascular endothelial growth factor
recombinant fusion proteins
receptors, vascular endothelial growth factor

---
https://pharmacomedicale.org/medicaments/par-specialites/item/medicaments-de-la-dmla
2018
false
true
false
France
intravitreal injections
Ranibizumab
Bevacizumab
aflibercept
receptors, vascular endothelial growth factor
vascular endothelial growth factors
angiogenesis inhibitors
Tyrosine Kinase Inhibitors
drug information
wet macular degeneration
recombinant fusion proteins
receptors, vascular endothelial growth factor

---
https://www.has-sante.fr/portail/jcms/c_2800955/fr/place-dans-la-strategie-therapeutique-de-lucentis-eylea-et-de-leurs-comparateurs-cliniquement-pertinents-dans-la-forme-neovasculaire-humide-de-la-dmla
2017
false
false
false
France
French
evaluation of the transparency committee
intravitreal injections
wet macular degeneration
comparative effectiveness research
vascular endothelial growth factor a
Ranibizumab
ranibizumab
treatment outcome
aflibercept
aflibercept
Bevacizumab
angiogenesis inhibitors
risk management
receptors, vascular endothelial growth factor
recombinant fusion proteins

---
http://www.has-sante.fr/portail/jcms/c_2045913/fr/decision-n-2015-0178/dc/sem-du-8-juillet-2015-du-college-de-la-haute-autorite-de-sante-adoptant-la-recommandation-relative-a-la-prise-en-charge-a-titre-derogatoire-d-avastin-bevacizumab-dans-le-cadre-d-une
2015
false
true
false
France
French
guidelines for drug use
French pre-residency program examination
wet macular degeneration
Bevacizumab
bevacizumab
continuity of patient care
intravitreal injections
intravitreal injections
drug prescriptions
treatment outcome
Bevacizumab
vascular endothelial growth factors

---
http://www.cochrane.org/fr/CD004004
2010
false
true
false
France
United Kingdom
treatment outcome
wet macular degeneration
review of literature
french abstract

---
Nous contacter.
31/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.